The Tricvalve® Transcatheter Bicaval Valve System is designed for the treatment of patients with severe tricuspid insufficiency, a form of valvular heart disease
Search
Displaying 21 - 40 of 70
Experts convene to advance surgical techniques and outcomes in aortic valve repair
The collaboration aims to develop and validate AI tools that support clinicians in making more informed decisions, leading to better outcomes for patients
Canada’s Minister of Mental Health and Addictions announced at the Heart Institute new initiatives to reduce tobacco-related harm across the country
Dr. D. S. Beanlands presided over a golden age of growth in clinical care and training as the Heart Institute evolved in size and stature
The funding will support UOHI researchers to close knowledge gaps and inform strategies to improve heart disease diagnosis, treatment and healthcare systems design.
Congratulations Drs. Kelly Cobey, Mireille Ouimet and Heather Tulloch
Researchers recommend a unified framework to improve care for patients with heart disease.
The Grant-in-Aid Program provides operating support for important, innovative research in heart disease and stroke
Report explores how Canada can protect sensitive research while continuing to support innovation and open science
Dr. Kelly Cobey will have the opportunity to shape evidence-based policy in Canada
Those named to the College represent the emerging generation of scholarly, artistic and scientific leadership in Canada
Dr. Alarcón is at the forefront of developing innovative peptide-based materials to help repair damaged tissues and organs
Dr. Kyoung-Han Kim will receive nearly one million dollars from the Canadian Institutes of Health Research Spring 2024 Project Grant Program
Funding for Dr. Kyoung-Han Kim’s innovative research project will be delivered through the Ontario Research Fund and the Early Researcher Awards
Research conducted in the Bioengineering and Therapeutic Solutions (BEaTS) Laboratory at the University of Ottawa Heart Institute (UOHI) has resulted in the development of a library of bioinspired molecules that can be assembled to mimic tissue structures similar to those found in humans.
Funding supports innovative research initiatives aimed at improving health outcomes for Canadians and people around the world
Media and members of the community are invited to join Dalton McGuinty, University of Ottawa Heart Institute chairman of the board, on March 28 for a ceremony to usher in Dr. Rob Beanlands as the Heart Institute’s next president and CEO and to recognize the legacy of Dr. Thierry Mesana.
The Canadian Centre for Rare Cardiac Conditions will host the 3rd Annual Rare Cardiac Conditions Conference on February 28, coinciding with International Rare Disease Day
Use of the VARIPULSE™ Platform marks a significant milestone in the treatment of atrial fibrillation.